In the wake of a big pharmaceutical news, Sun Pharmaceutical Industries, a leading Indian pharma company, announced through a massive $11.7 billion deal that it has successfully gained control of Organon, a major company dealing with women’s health and generic medicines. This development came at the same time as companies were involved in other high-stakes mergers and it is a strong indicator that big pharma companies are resorting to mergers to safeguard their profits, add value to their product portfolios,
